242 related articles for article (PubMed ID: 36006226)
1. Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.
Flavell DJ; Flavell SU
Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006226
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.
Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE
Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330
[TBL] [Abstract][Full Text] [Related]
3. Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.
Gilabert-Oriol R; Weng A; Mallinckrodt Bv; Melzig MF; Fuchs H; Thakur M
Curr Pharm Des; 2014; 20(42):6584-643. PubMed ID: 25341935
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B
Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
[TBL] [Abstract][Full Text] [Related]
5. Ribosome-inactivating proteins: from plant defense to tumor attack.
de Virgilio M; Lombardi A; Caliandro R; Fabbrini MS
Toxins (Basel); 2010 Nov; 2(11):2699-737. PubMed ID: 22069572
[TBL] [Abstract][Full Text] [Related]
6. From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?
Ardini M; Vago R; Fabbrini MS; Ippoliti R
Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136517
[TBL] [Abstract][Full Text] [Related]
7. Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.
Weidle UH; Tiefenthaler G; Schiller C; Weiss EH; Georges G; Brinkmann U
Cancer Genomics Proteomics; 2014; 11(1):25-38. PubMed ID: 24633317
[TBL] [Abstract][Full Text] [Related]
8. Ribosome-inactivating proteins: from toxins to useful proteins.
Stirpe F
Toxicon; 2013 Jun; 67():12-6. PubMed ID: 23462379
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxins in cancer therapy: Review and update.
Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
[TBL] [Abstract][Full Text] [Related]
10. Dianthin and Its Potential in Targeted Tumor Therapies.
Fuchs H
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614697
[TBL] [Abstract][Full Text] [Related]
11. [Highly toxic type Ⅱ ribosome-inactivating proteins ricin and abrin and their detection methods: a review].
Liang L; Xia J; Liu C; Liu S
Se Pu; 2021 Mar; 39(3):260-270. PubMed ID: 34227307
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxin construction with a ribosome-inactivating protein from barley.
Ebert RF; Spryn LA
Bioconjug Chem; 1990; 1(5):331-6. PubMed ID: 2098110
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Polito L; Bortolotti M; Pedrazzi M; Bolognesi A
Toxins (Basel); 2011 Jun; 3(6):697-720. PubMed ID: 22069735
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the uses and applications of ribosome-inactivating proteins from plants.
Girbés T; Ferreras JM; Iglesias R; Citores L; De Torre C; Carbajales ML; Jiménez P; De Benito FM; Muñoz R
Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):461-71. PubMed ID: 8828901
[TBL] [Abstract][Full Text] [Related]
15. Blood clearance and organ distribution and tissue concentration of native, homopolymerized and IgG-conjugated ribosome-inactivating proteins.
Barbieri L; Battelli MG; Stirpe F
Xenobiotica; 1990 Dec; 20(12):1331-41. PubMed ID: 2075751
[TBL] [Abstract][Full Text] [Related]
16. Ribosome-Inactivating Proteins from Plants: A Historical Overview.
Bolognesi A; Bortolotti M; Maiello S; Battelli MG; Polito L
Molecules; 2016 Nov; 21(12):. PubMed ID: 27898041
[TBL] [Abstract][Full Text] [Related]
17. The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.
Rust A; Partridge LJ; Davletov B; Hautbergue GM
Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29076988
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.
Bolognesi A; Polito L; Tazzari PL; Lemoli RM; Lubelli C; Fogli M; Boon L; de Boer M; Stirpe F
Br J Haematol; 2000 Aug; 110(2):351-61. PubMed ID: 10971392
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
20. Ribosome-inactivating proteins up to date.
Stirpe F; Barbieri L
FEBS Lett; 1986 Jan; 195(1-2):1-8. PubMed ID: 3510899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
